- Home
- PRCT vs APLS Comparison
PRCT vs APLS Comparison
Compare PRCT & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCT
- APLS
- Stock Information
- Founded
- PRCT 2009
- APLS 2009
- Country
- PRCT United States
- APLS United States
- Employees
- PRCT N/A
- APLS N/A
- Industry
- PRCT Medical Specialities
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- PRCT Health Care
- APLS Health Care
- Exchange
- PRCT Nasdaq
- APLS Nasdaq
- Market Cap
- PRCT 5.3B
- APLS 4.4B
- IPO Year
- PRCT 2021
- APLS 2017
- Fundamental
- Price
- PRCT $94.45
- APLS $27.75
- Analyst Decision
- PRCT Strong Buy
- APLS Buy
- Analyst Count
- PRCT 6
- APLS 19
- Target Price
- PRCT $89.50
- APLS $49.89
- AVG Volume (30 Days)
- PRCT 1.2M
- APLS 4.0M
- Earning Date
- PRCT 10-28-2024
- APLS 11-05-2024
- Dividend Yield
- PRCT N/A
- APLS N/A
- EPS Growth
- PRCT N/A
- APLS N/A
- EPS
- PRCT N/A
- APLS N/A
- Revenue
- PRCT $199,843,000.00
- APLS $715,216,000.00
- Revenue This Year
- PRCT $67.06
- APLS $95.59
- Revenue Next Year
- PRCT $40.59
- APLS $13.77
- P/E Ratio
- PRCT N/A
- APLS N/A
- Revenue Growth
- PRCT 71.71
- APLS 162.10
- 52 Week Low
- PRCT $33.45
- APLS $24.34
- 52 Week High
- PRCT $103.81
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- PRCT 58.77
- APLS 47.09
- Support Level
- PRCT $85.75
- APLS $25.76
- Resistance Level
- PRCT $103.81
- APLS $30.80
- Average True Range (ATR)
- PRCT 4.68
- APLS 1.84
- MACD
- PRCT -0.62
- APLS 0.04
- Stochastic Oscillator
- PRCT 48.17
- APLS 52.79
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.